OBJECTIVE: To introduce the overseas clinical application of new dosage forms of amphotericin B in the treatment of deep mycosis.
Preparation and drug-release property of amphotericin B-loaded chitosan-polylactic acid nanoparticles
Objective To explore the clinical significance of treatment of cryptococcal meningitis with amphotericin B( AMB) by quantitatively counting cryptococcus neoformans in CSF.
Efficacy of topical amphotericin B treatment in the management of refractory traumatic keratomycosis
